| abstract |
Compounds of Formula (I) and the pharmaceutically acceptable salts thereof are disclosed. The variables. R 1 -R 13 , m, n, o, and p are disclosed herein. The compounds are useful for treating Gaucher disease and inhibiting the onset of Gaucher disease symptoms in a patient having a GBA gene mutation and for treating Parkinson's disease. Pharmaceutical compositions containing compounds of Formula (I) and methods of treatment comprising administering compounds of Formula (I) are also disclosed. |